
TUROLLA ELIA ANNA
- U48, Piano: 1I, Stanza: 114
Pubblicazioni
Monaco, L., Crivellaro, C., De Bernardi, E., Bono, F., Casati, G., Seminati, D., et al. (2025). Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 19 [10.1177/17534666251384433]. Dettaglio
Iannone, M., Kravicz, M., Rainone, P., Antoniou, A., Stucchi, S., Valtorta, S., et al. (2025). Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1566257]. Dettaglio
Iannone, M., Valtorta, S., Stucchi, S., Altomonte, S., Turolla, E., Vino, E., et al. (2024). Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method. EJNMMI RADIOPHARMACY AND CHEMISTRY, 9(1) [10.1186/s41181-024-00280-0]. Dettaglio
Meazza Prina, M., Gotuzzo, I., Cazzaniga, M., De Bernardi, E., Cafaro, P., Capici, S., et al. (2023). Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study. Intervento presentato a: SABCS - San Antonio Breast Cancer Symposium - DEC 06-10, 2022, San Antonio, Texas, USA [10.1158/1538-7445.SABCS22-P6-01-42]. Dettaglio
Monaco, L., De Bernardi, E., Bono, F., Cortinovis, D., Crivellaro, C., Elisei, F., et al. (2022). The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 49(10), 3401-3411 [10.1007/s00259-022-05783-z]. Dettaglio